Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Shire
Company Monitoring Page for Shire
latest headlines for company on cafepharma
AbbVie Kills Shire Merger, But Door Opens for Bristol-Myers Squibb?
TheStreet.com
Fri, 10/17/14 - 09:15 am
Tags:
AbbVie
,
Shire
,
M&A
,
Bristol-Myers Squibb
AbbVie’s Termination Fee Is the Third Largest Ever Paid
WSJ Online
Thu, 10/16/14 - 06:48 pm
Tags:
AbbVie
,
Shire
,
M&A
AbbVie Board Recommends Holders Vote Against Shire Deal
Bloomberg
Thu, 10/16/14 - 07:47 am
Tags:
AbbVie
,
Shire
,
tax inversions
,
M&A
AbbVie, Shire Have Options Besides Each Other: Real M&A
Bloomberg
Wed, 10/15/14 - 02:54 pm
Tags:
M&A
,
AbbVie
,
Shire
,
tax inversions
,
Allergan
,
Valeant Pharmaceuticals
Shire says AbbVie should not renege on merger deal
Yahoo/Reuters
Wed, 10/15/14 - 08:07 am
Tags:
Shire
,
AbbVie
,
M&A
,
tax inversions
AbbVie Board to Reconsider Recommendation for Shire Deal
Bloomberg
Tue, 10/14/14 - 09:19 pm
Tags:
AbbVie
,
Shire
,
M&A
The top 10 most expensive drugs of 2013
Fierce Pharma
Tue, 10/14/14 - 10:05 am
Tags:
drug pricing
,
Soliris
,
Alexion
,
Naglazyme
,
Biomarin
,
Kalydeco
,
Vertex
,
Cinryze
,
Shire
,
Sprycel
,
Bristol-Myers Squibb
,
Pomalyst
,
Celgene
,
Xyrem
,
Jazz Pharmaceuticals
,
Erbitux
,
Merck KGaA
,
Revlimid
,
Questcor
,
Mallinckrodt
,
H.P. Acthar Gel
Shire delays ADD medication submission
Medical Marketing and Media
Thu, 10/9/14 - 05:09 pm
Tags:
Shire
,
FDA
,
SHP 465
,
ADD
AbbVie Tell Shire Employees: The Merger Will Go On
WSJ Online
Mon, 09/29/14 - 08:14 pm
Tags:
AbbVie
,
Shire
,
M&A
AbbVie Said to Weigh More Shire Financing After U.S. Rule
Bloomberg
Fri, 09/26/14 - 10:47 am
Tags:
AbbVie
,
Shire
,
tax inversions
,
M&A
Hey, Big Pharma: When the feds swoop in, be nice. It worked for Shire
Fierce Pharma
Thu, 09/25/14 - 09:58 am
Tags:
Big Pharma
,
whistleblower lawsuits
,
False Claims Act
,
Shire
,
off-label
AbbVie May Be Next Big Loser In Tax Inversion Race
Bidness Etc.
Thu, 09/25/14 - 09:49 am
Tags:
AbbVie
,
tax inversions
,
Shire
,
M&A
Shire pays $56.5M to resolve whistleblower claims it improperly marketed drugs
Bizjournals.com
Wed, 09/24/14 - 10:14 pm
Tags:
Shire
,
ADHD
,
False Claims Act
,
Adderall XR
,
Vyvanse
,
whistleblower lawsuits
Tax-deal crackdown's victims, say analysts? Mylan and Abbott, not Pfizer and AZ
Fierce Pharma
Tue, 09/23/14 - 05:45 pm
Tags:
Mylan Labs
,
Pfizer
,
AstraZeneca
,
Shire
,
AbbVie
,
tax inversions
,
Abbott Labs
Who loses in biopharma as Treasury moves to block tax inversions?
Fierce Biotech
Tue, 09/23/14 - 08:00 am
Tags:
tax inversions
,
Pfizer
,
Shire
,
AstraZeneca
,
AbbVie
,
Salix
Inversion Deal Crackdown Sends AstraZeneca, Shire Down
Bloomberg
Tue, 09/23/14 - 07:37 am
Tags:
AstraZeneca
,
Shire
,
tax inversions
AbbVie Sued by Pension Fund Over $54.5 Billion Shire Deal
Bloomberg
Tue, 09/16/14 - 04:52 pm
Tags:
AbbVie
,
Shire
,
M&A
Shire eating disorder drug gets U.S. priority review
Yahoo/Reuters
Mon, 09/15/14 - 10:27 am
Tags:
Shire
,
binge eating disorder
,
Vyvanse
EU to decide on $52 bln AbbVie, Shire deal by Oct. 16
Yahoo/Reuters
Mon, 09/15/14 - 10:24 am
Tags:
Europe
,
AbbVie
,
Shire
Should Companies Reimburse Executives for Inversion Taxes?
WSJ Pharmalot
Tue, 09/2/14 - 10:16 am
Tags:
tax inversions
,
AbbVie
,
Shire
,
Covidien
,
Medtronic
,
M&A
Pages
« first
‹ previous
…
14
15
16
17
18
19
20
21
22
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
cafepharma is a: rock, tree, site
*
Fill in the blank.